High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.3M
$3,260,618
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CFO
Other
|
2026-01-21 | $368,400 | M | Form 4 |
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Somaiya Mayur Ian
• CFO
10b5-1 SellΔOwn -15.7%
2026-01-21
$1,336,217Largex2
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CFO
10b5-1 SellΔOwn -15.7%
|
2026-01-21 | $1,336,217Largex2 | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CFO
Other
|
2026-01-20 | $557,600 | M | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CFO
10b5-1 Sell
|
2026-01-20 | $1,924,401Largex3 | S | Form 4 |